Literature DB >> 19347578

Perspective on the clinical application of troponin in heart failure and states of cardiac injury.

Almasa Bass1, J Herbert Patterson, Kirkwood F Adams.   

Abstract

The ability to measure the appearance of cardiac specific forms of troponin in the blood represents a major advance in the clinical assessment of patients with many types of cardiovascular disease, especially acute coronary syndromes. In this review we focus on the utility of troponin in heart failure where this biomarker has emerged as an independent predictor of prognosis providing information beyond clinical assessment and measurement of b-type natriuretic peptides. The novel clinical role of troponin in a variety of states associated with myocardial injury, including chemotherapy and patients with cardiovascular risk factors, is discussed.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19347578     DOI： 10.1007/s10741-008-9124-8

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN： 1382-4147            Impact factor:   4.214


  77 in total

1.  Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis.

Authors:  Michael P Hudson; Christopher M O'Connor; Wendy A Gattis; Gudaye Tasissa; Vic Hasselblad; Cathy M Holleman; Laura H Gaulden; Frank Sedor; E Magnus Ohman
Journal:  Am Heart J       Date:  2004-03       Impact factor: 4.749

2.  National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes.

Authors:  Fred S Apple; Robert L Jesse; L Kristin Newby; Alan H B Wu; Robert H Christenson
Journal:  Circulation       Date:  2007-03-23       Impact factor: 29.690

3.  Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators.

Authors:  R H Christenson; S H Duh; L K Newby; E M Ohman; R M Califf; C B Granger; S Peck; K S Pieper; P W Armstrong; H A Katus; E J Topol
Journal:  Clin Chem       Date:  1998-03       Impact factor: 8.327

4.  The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF).

Authors:  Mihai Gheorghiade; Wendy Gattis Stough; Kirkwood F Adams; Allan S Jaffe; Victor Hasselblad; Christopher M O'Connor
Journal:  Am J Cardiol       Date:  2005-09-19       Impact factor: 2.778

5.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.

Authors:  E M Antman; M J Tanasijevic; B Thompson; M Schactman; C H McCabe; C P Cannon; G A Fischer; A Y Fung; C Thompson; D Wybenga; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-31       Impact factor: 91.245

6.  Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure.

Authors:  Junnichi Ishii; Wei Cui; Fumihiko Kitagawa; Takahiro Kuno; Yuu Nakamura; Hiroyuki Naruse; Yoshihisa Mori; Takashi Ishikawa; Youichi Nagamura; Takeshi Kondo; Hisaji Oshima; Masanori Nomura; Kouji Ezaki; Hitoshi Hishida
Journal:  Clin Chem       Date:  2003-12       Impact factor: 8.327

Review 7.  Peripartum cardiomyopathy: recent insights in its pathophysiology.

Authors:  Denise Hilfiker-Kleiner; Karen Sliwa; Helmut Drexler
Journal:  Trends Cardiovasc Med       Date:  2008-07       Impact factor: 6.677

Review 8.  The troponin complex and regulation of muscle contraction.

Authors:  C S Farah; F C Reinach
Journal:  FASEB J       Date:  1995-06       Impact factor: 5.191

9.  Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro.

Authors:  D Kaye; D Pimental; S Prasad; T Mäki; H J Berger; P L McNeil; T W Smith; R A Kelly
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

10.  Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation.

Authors:  M H M Hessel; D E Atsma; E J M van der Valk; W H Bax; M J Schalij; A van der Laarse
Journal:  Pflugers Arch       Date:  2007-10-02       Impact factor: 3.657
View more
  3 in total

1.  Use of novel and conventional biomarkers for management of patients with heart failure.

Authors:  Kelly H Schlendorf; Edward K Kasper
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-12

Review 2.  PD-1/PD-L1 Inhibitor-Associated Myocarditis: Epidemiology, Characteristics, Diagnosis, Treatment, and Potential Mechanism.

Authors:  Hao Dong; Yihang Qi; Xiangyi Kong; Zhongzhao Wang; Yi Fang; Jing Wang
Journal:  Front Pharmacol       Date:  2022-04-19       Impact factor: 5.988

3.  Cardiac troponin T is associated with mortality in patients admitted to critical care in a UK major trauma centre: a retrospective database analysis.

Authors:  Kate Crewdson; Julian Thompson; Matt Thomas
Journal:  J Intensive Care Soc       Date:  2018-04-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.